亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma

医学 鼻咽癌 放射治疗 随机对照试验 外科 肿瘤科 内科学
作者
Kathryn R. Tringale,Nancy Y. Lee
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:22 (6): e218-e218 被引量:3
标识
DOI:10.1016/s1470-2045(21)00238-2
摘要

In the randomised, controlled, phase 3 trial published in The Lancet Oncology reported by You-Ping Liu and colleagues, 1 Liu Y-P Wen Y-H Tang J et al. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021; 22: 381-390 Summary Full Text Full Text PDF PubMed Scopus (8) Google Scholar 200 patients with locally recurrent nasopharyngeal carcinoma (NPC) were enrolled and randomly assigned to endoscopic nasopharyngectomy (ENPG) or intensity-modulated radiotherapy (IMRT). The aims of the study were to compare the safety and efficacy of the two treatment methods. The results favoured ENPG in terms of toxicity and overall survival, but not distant metastasis-free survival. 1 Liu Y-P Wen Y-H Tang J et al. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021; 22: 381-390 Summary Full Text Full Text PDF PubMed Scopus (8) Google Scholar Exploratory analyses identified no benefit of ENPG for patients with rT3 tumours. We commend the authors on completing the first randomised, controlled trial comparing salvage treatments for recurrent NPC; however, we would like to raise concerns and caution readers to not change practice based solely on these results. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialEndoscopic surgery significantly improved overall survival compared with IMRT in patients with resectable locally recurrent NPC. These results suggest that ENPG could be considered as the standard treatment option for this patient population, although long-term follow-up is needed to further determine the efficacy and toxicity of this strategy. Full-Text PDF Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinomaWe read with interest the results of the randomised, controlled, phase 3 trial by You-Ping Liu and colleagues1 in The Lancet Oncology, in which they compared endoscopic nasopharyngectomy (ENPG) to re-irradiation using intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC) with an isolated locoregional recurrence. With overall survival as the primary endpoint, the investigators reported that overall survival was better with ENPG than with IMRT (hazard ratio 0·47, 95% CI 0·29–0·76). Full-Text PDF Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma – Authors' replyWe thank Melvin Chua and colleagues and Kathryn Tringale and Nancy Lee for their comments on our recent Article in The Lancet Oncology.1 We agree with Chua and colleagues that this trial represents a subset of patients with crucial selection criteria for tumour resectability, and the results do not justify recommending endoscopic nasopharyngectomy (ENPG) as the new standard of care for all patients with locoregional recurrent nasopharyngeal carcinoma (rNPC). Both Chua and colleagues and Tringale and Lee raised the question about the allowance of a relatively hypofractionated intensity-modulated radiotherapy (IMRT) regimen. Full-Text PDF

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
上官若男的应助被fufu采纳,获得10
3秒前
5秒前
6秒前
6秒前
星辰大海的应助被科研通管家采纳,获得10
6秒前
田様的应助被科研通管家采纳,获得10
6秒前
6秒前
烟花的应助被科研通管家采纳,获得10
6秒前
爆米花的应助被科研通管家采纳,获得10
6秒前
亦周完成签到,获得积分10
7秒前
传奇3的应助被科研通管家采纳,获得10
7秒前
今后的应助被科研通管家采纳,获得10
7秒前
RUINNNO完成签到,获得积分10
8秒前
9秒前
秀丽战斗机完成签到,获得积分20
10秒前
香果完成签到,获得积分10
12秒前
丘比特的应助被初初初啊采纳,获得10
12秒前
风趣纸鹤发布了新的文献求助10
12秒前
14秒前
15秒前
77完成签到 ,获得积分10
17秒前
19秒前
22秒前
22秒前
大华完成签到 ,获得积分10
24秒前
情怀的应助被初初初啊采纳,获得10
27秒前
110发布了新的文献求助10
29秒前
风趣纸鹤完成签到,获得积分10
29秒前
29秒前
奶龙完成签到 ,获得积分10
31秒前
仰勒完成签到 ,获得积分10
37秒前
小二郎的应助被Lucky采纳,获得10
39秒前
小二郎的应助被萧雨墨采纳,获得10
41秒前
奶蛙完成签到 ,获得积分10
41秒前
43秒前
科研通AI6.2的应助被ZT1采纳,获得10
44秒前
45秒前
45秒前
Kelly完成签到 ,获得积分10
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190060
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851884
捐赠科研通 7788155
什么是DOI,文献DOI怎么找? 3436233
关于科研通互助平台的介绍 2559935
邀请新用户注册赠送积分活动 2482792